Previously, we demonstrated activation of alloreactive HLA-DP1-specific CD4+ T cells leading to GvHD in two patients with a CMV reactivation after a CD4+ T-cell infusion from an HLA-DP1 mismatched donor (19). The gene discussed is CD4; the disease is graft versus host disease.